New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; 15 of the 33 sources its claims cite were checked for support.
Abstract
Abstract Background Bone marrow-derived mesenchymal stem cell ( BM MSC)-based therapy has become a major focus for treating liver fibrosis/cirrhosis. However, although these cell therapies promote the treatment of this disease, the heterogeneity of BM MSCs, which causes insufficient efficacy during clinical trials, has not been addressed. In this study, we describe a novel Percoll–Plate–Wait procedure (PPWP) for the isolation of an active cell subset from BM MSC cultures that was characterized by the expression of neuroglial antigen 2 (NG2/ BM MSCs). Methods By using the key method of PPWP and other classical biological techniques we compared NG2/ BM MSCs with parental BM MSCs in biological and functional characteristics within a well-defined diethylnitrosamine (DEN)-induced liver fibrosis/cirrhosis injury male C57BL/6 mouse model also in a culture system. Of note, the pathological alterations in the model is quite similar to humans’. Results The NG2/ BM MSCs revealed more advantages compared to parental BM MSC s. They exhibited greater proliferation potential than parental BM MSCs, as indicated by Ki-67 immunofluorescence (IF) staining. Moreover, higher expression of SSEA-3 (a marker specific for embryonic stem cells) was detected in NG2/ BM MSCs than in parental BM MSCs, which suggested that the “stemness” of NG2/ BM MSCs was greater than that of parental BM MSCs. In vivo studies revealed that an injection of NG2/ BM MSCs into mice with ongoing DEN-induced liver fibrotic/cirrhotic injury enhanced repair and functional recovery to a greater extent than in mice treated with parental BM MSCs. These effects were associated with the ability of NG2/ BM MSCs to differentiate into bile duct cells (BDCs). In particular, we discovered for the first time that NG2/ BM MSCs exhibit unique characteristics that differ from those of parental BM MSCs in terms of producing liver sinusoidal endothelial cells (LSECs) to reconstruct injured blood vessels and sinusoidal structures in the diseased livers, which are important for initiating hepatocyte regeneration. This unique potential may also suggest that NG2/ BM MSCs could be an novel off-liver progenitor of LSECs. Ex vivo studies revealed that the NG2/ BM MSCs exhibited a similar trend to that of their in vivo in terms of functional differentiation responding to the DEN-diseased injured liver cues. Additionally, the obvious core role of NG2/ BM MSCs in supporting the functions of BM MSCs in bile duct repair and BDC-mediated hepatocyte regeneration might also be a novel finding. Conclusions Overall, the PPWP-isolated NG2/ BM MSCs could be a novel effective cell subset with increased purity to serve as a new therapeutic tool for enhancing treatment efficacy of BM MSCs and special seed cell source (BDCs, LSECs) also for bioliver engineering.
Overview
CoChat Summary
## TL;DR
This paper reports a Percoll–Plate–Wait procedure (PPWP) to isolate an NG2-expressing subset from heterogeneous bone marrow MSC cultures and compares these cells with parental BMMSCs in a DEN-induced mouse model of liver fibrosis/cirrhosis and in culture. The NG2/BMMSC subset showed higher purity, greater proliferation/stemness markers, and stronger repair/differentiation effects than parental BMMSCs, including biliary and sinusoidal repair.
## Key findings
- PPWP isolated NG2+ cells from BMMSC cultures with 95–98% purity in both mouse and human samples; in human BMMSCs, the isolated subset reached >95% purity.
- In culture, mouse NG2/BMMSCs proliferated more than parental BMMSCs; at 72 h, 49.71% ± 5.46% of NG2/BMMSCs were Ki-67+ versus 19.04% ± 6.19% of parental BMMSCs, described as an approximately 3-fold higher proliferating fraction.
- In DEN-injured mice, NG2/BMMSCs improved biliary repair more than parental BMMSCs, with reported relative improvements of about 1.5-fold for CK7 (14.17 ± 5.99 / 6.12 ± 3.83) and 2.3-fold for CK19 (26.71 ± 4.39 / 14.50 ± 3.57).
- NG2/BMMSCs also promoted sinusoidal/LSEC-like repair: in mouse cultures in DEN-conditioned media, 56% ± 18.01 of Lyve-1+ cells developed from NG2/BMMSCs versus 28% ± 8.31% from parental BMMSCs; in the in vivo mouse experiment, host Lyve-1+ cells increased by about 51% after NG2/BMMSC treatment.
- In human cells, DEN-conditioned media produced more CK19+ biliary-like cells from h-NG2/BMMSCs (41.71% ± 9.73%) than from parental h-BMMSCs (27.34% ± 6.37%), and Lyve-1+ cells were also higher from h-NG2/BMMSCs (66.38% ± 12.8%) than from parental h-BMMSCs (15.21% ± 7.25%).
## Methods
- The study isolated NG2+ cells from mouse and human BMMSC cultures using the PPWP method, then compared NG2/BMMSCs with parental BMMSCs in vitro and after transplantation.
- Mouse experiments used male C57BL/6 mice in a DEN-induced liver fibrosis/cirrhosis model; treatment groups included DEN + NG2/BMMSCs (n = 15), DEN + BMMSCs (n = 15), DEN + PBS (n = 10), and naive (n = 10).
- Main analyses included flow cytometry, immunofluorescence, immunohistochemistry, RT-qPCR, CCK-8 proliferation assays, serum liver-function tests, and comparison of differentiation into cholangiocyte/BDC and endothelial/LSEC lineages in diseased liver tissue or DEN-conditioned media.
## Limitations
- The paper states that the mechanisms and signaling pathways remain unknown, including what mediates enhanced endogenous regeneration and whether NG2+ cells act through endogenous hepatic progenitors or by supporting existing cells.
- The paper explicitly notes a limitation: “NG2/BMMSC subset sourced human and animals sounds existing bias in the DEN mouse model and probably more relative animal models are required to do the evaluation.”
- Evident from the text: several claims rely on a single DEN mouse model, and the paper reports that some assessments were not blinded at all stages in the mouse study, which may limit robustness.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
11 Valid · 1 Not valid · 13 Not checked · 95 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“O’Connor et al. [7] described a active subset with coexpression of the neuron-glial antigen 2 (NG2) immunophenotype and CD146 within human marrow-derived MSCs (h-BMMSCs)”
§ New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis > Background
What the sources say
- Supportedcites [7] Russell KC, Tucker HA, Bunnell BA, Andreeff M, Schober W, Gaynor AS, Strickler KL, Lin S, Lacey MR, O’Connor KC. Cell-surface expression of neuron-glial antigen 2 (NG2) and melanoma cell adhesion molecule (CD146) in heterogeneous cultures of marrow-derived mesenchymal stem cells. J Tissue Eng Part A. 2013;19(19–20):2253–66. source
The Results describe a subset of human marrow-derived MSCs selected for high NG2 and high CD146 expression that had elevated colony-forming efficiency and proliferative potential. The paper also notes that adding the CD146-high selection did not significantly improve division or survival beyond NG2-high selection; the claim does not assert that it did. (LLM, conf=0.91)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“and promote functional recovery in disease models [21]”
§ New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis > Background
What the sources say
- Supportedcites [21] Bai L, Hecker J, Kerstetter A, Miller RH. Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis. J Neurosci Bull. 2013;29(2):239–50. source
The Results section reports that mice with EAE, a disease model, showed considerable functional improvement after receiving NG2+ cells, while control animals' deficits remained relatively constant. The Discussion also identifies EAE as an animal model of demyelinating disease. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“which has been stably used for the isolation of NG2+ cells from multiple adult tissues [21, 23]”
§ New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis > Background
What the sources say
- Partly supportedcites [21] Bai L, Hecker J, Kerstetter A, Miller RH. Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis. J Neurosci Bull. 2013;29(2):239–50. sourceExperimental — accuracy not yet measured
The Methods section, “Purification of Mouse Adult Spinal Cord NG2+ Cells Using Percoll Gradient” (page unavailable), describes isolating cells from adult mouse spinal cords. The Results section, “Purification and characterization of Adult Mouse spinal cord-Derived NG2+ cells” (page unavailable), reports that more than 98% of cells were NG2+ by the second passage. Our copy does not identify the procedure as PPWP or establish its stable use across multiple adult tissues. (LLM, conf=0.84)
- Partly supportedcites [23] Zhang H, Siegel CT, Shuai L, Lai J, Zeng L, Zhang Y, Lai X, Bie P, Bai L. Repair of liver mediated by adult mouse liver neuro-glia antigen 2-positive progenitor cell transplantation in a mouse model of cirrhosis. J Sci Rep. 2016;6:21783. sourceExperimental — accuracy not yet measured
The Methods section (page not supplied) describes using the Percoll-Plate-Wait procedure to isolate NG2+ cells from adult mouse liver. The Results report that the isolated cells retained similar characteristics through eight passages. Our copy does not establish that the procedure has been used to isolate NG2+ cells from multiple adult tissues. (LLM, conf=0.87)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“IF staining for Ki-67 (red, arrows) revealed that the proliferation potential of the cells was greater than that of the parental h-BMMSCs (Fig. 6Ba, arrows, b), similar to what was observed in vivo [7].”
§ New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis > Results > Characterization of ex vivo-expanded NG2+ cells isolated from human marrow MSCs and the advantages of these cells in exerting therapeutic effects on DEN-induced liver disease Finally, we evaluated whether human marrow MSC-sourced NG2+ cells (h-NG2/BMMSCs) could also be advanced like animal cells, aiming to improv the quality and enhance the efficacy of heterogeneous human BMMSCs (h-BMMSCs). An FCM assay detected ∼ 8–10% of the assumed NG2- cells (an arrow, Suppl. Fig. S3A) in the normal h-BMMSC cultures (Fig. 6Ab, a bold arrow). Using the PPWP approach (Suppl. Fig. S1A), we successfully obtained the appropriate fraction (arrow, lower NG2+ cell proportion; Suppl. Fig. S3Ba) and expanded it in vitro (Fig. 6Aa; Suppl. Fig. S3Bb). The in vitro-expanded h-NG2/BMMSCs showed > 95% purity, as determined by both IF staining (red, an arrow, Suppl. Fig. S3Ca) and FCM (Suppl. Fig. S3Cb), suggesting that the PPWP approach is also applicable to human cells. A series of comparison studies revealed that the transverse/longitudinal diameter of h-NG2/BMMSCs was also significantly larger than that of parental h-BMMSCs (Fig. 6Aa, a thin arrow, c, **p < 0.001). IF staining for Ki-67 (red, arrows) revealed that the proliferation potential of the cells was greater than that of the parental h-BMMSCs (Fig. 6Ba, arrows, b), similar to what was observed in vivo [7]. In the cultures, we also observed that the larger cells (bold arrows, assumed to be NG2+ cells) produced smaller spindle-shaped cells (thin arrows, Fig. 6Ca, S1 and S2 represent individual cultures) that were similar to those of the animal cells described above, were more strongly labeled by SSEA-3 of h-NG2/BMMSCs than parental h-BMMSCs(arrows, Fig. 6Cb, arrow, c), and formed larger colonies (Fig. 6Cb, a box), supporting the greater “stemness” of h-NG2/BMMSCs than h-BMMSCs. After the cells were infused into the DEN model at 6–7 weeks post-DEN admonstration, h-NG2/BMMSCs also exhibited advantages in terms of endogenous cholangiocyte regeneration and functional recovery compared with parental h-BMMSCs four weeks after cell transplantation. For example, the number of host CK19+ cholangiocytes (red) was greater (29.18 ± 3.96; Fig. 6Da; left panels) than that of the mice that received parental h-BMMSCs (8.50 ± 4.62; Fig. 6Da; right panels; b, arrows), an approximately 4.5-fold increase (Fig. 6Dc). The significant potential of h-NG2/BMMSCs was also shown for host mature hepatocyte regeneration, as indicated by the presence of albumin(Alb, Fig. 6Dd, e, boxes)and G6Pc (Suppl. Fig. S3Da-c, arrows), another marker for mature hepatocytes [40], approximately 2-fold and 2.5-fold higher than that of parental h-BMMSCs, respectively (Fig. 6Df; Suppl. Fig. S3 Dd). By analyzing host ɑ-SMA expression via IF staining (red), we found that both cell types had the capacity to reduce the number of ɑ-SMA+ cells (Fig. 6Eb, c) compared to that in DEN-treated mice (Fig. 6Ea, boxes) 4 weeks after cell transplantation, but the significantly greater potential of h-NG2/BMMSCs was exhibited at both the protein (Fig. 6Ed, red bar, **p < 0.001) and mRNA (Fig. 6Ee, *P < 0.05) levels, suggesting that h-NG2/BMMSC treatment improved the fibrotic load. Further measurement of hepatic parameters in blood revealed that h-NG2/BMMSCs improved the serum levels of TBiL, DBiL, IBiL, ALP, LDL and Alb (Fig. 6Ef). This evidence could support the notion that h-NG2/BMMSCs have superior therapeutic effects to parental h-BMMSCs on liver diseases. Interestingly, when analyzed by performing IF staining (red) of Lyve-1 expression in the host liver, we obtained evidence similar to that collected for animal cells regarding sinusoidal repair in DEN-induced livers [Fig. 6F(a-d)]. We detected ∼ 5 ± 3.06 Lyve-1+ cells/per quarter area (b) in DEN mice, which was significantly lower than that in naive livers (a, ∼ 11.58 ± 3.72/quarter area/boxes; e, #p < 0.05). The number of Lyve-1+ cells was significantly greater in the h-NG2/BMMSC-treated mice than in the DEN-treated mice (c, ∼ 12 ± 3.72/quarter area/boxes; Fig. 6Fb, e red bar, **p > 0.001), and these numbers were comparable to those in the naive mice (Fig. 6Fa, e, gray bar, p > 0.05). In contrast, compared with DEN-treated mice, mice that received h-BMMSCs (d) failed to stimulate host Lyve-1+ cells at either the protein (Fig. 6Fe, boxes, ns p > 0.05) or mRNA level, according to RT‒qPCR (Fig. 6Ff, ns p > 0.05), suggesting that human-sourced h-NG2/BMMSCs also possessed the unique property of reconstructing damaged sinusoidal structures. In addition, as determined using FCM, the h-NG2/BMMSCs expressed similar patterns of surface markers (Suppl. Fig. S3E), suggesting that the isolated h-NG2/BMMSCs still shared some characteristics with the h-BMMSCs. These findings indicate that the PPWP approach is suitable for human samples and that ex vivo-expanded human BMMSC-sourced NG2+ cells may be novel off-liver precursors of BDCs, particularly LSECs, and therapeutic tools for treating patients with liver fibrotic/cirrhotic diseases.
What the sources say
- Partly supportedcites [7] Russell KC, Tucker HA, Bunnell BA, Andreeff M, Schober W, Gaynor AS, Strickler KL, Lin S, Lacey MR, O’Connor KC. Cell-surface expression of neuron-glial antigen 2 (NG2) and melanoma cell adhesion molecule (CD146) in heterogeneous cultures of marrow-derived mesenchymal stem cells. J Tissue Eng Part A. 2013;19(19–20):2253–66. sourceExperimental — accuracy not yet measured
The Results report that low-scatter, NG2-high marrow MSCs had greater colony-forming efficiency than parental controls; the Discussion explicitly describes this as an in vitro finding (page unavailable). The paper does not establish the cited sentence’s in vivo comparison or use Ki-67 staining to demonstrate it. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“They exhibited greater proliferation potential than parental BMMSCs, as indicated by Ki-67 immunofluorescence (IF) staining.”
§ New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis > Abstract > Results The NG2/BMMSCs revealed more advantages compared to parentalBMMSCs. They exhibited greater proliferation potential than parental BMMSCs, as indicated by Ki-67 immunofluorescence (IF) staining. Moreover, higher expression of SSEA-3 (a marker specific for embryonic stem cells) was detected in NG2/BMMSCs than in parental BMMSCs, which suggested that the “stemness” of NG2/BMMSCs was greater than that of parental BMMSCs. In vivo studies revealed that an injection of NG2/BMMSCs into mice with ongoing DEN-induced liver fibrotic/cirrhotic injury enhanced repair and functional recovery to a greater extent than in mice treated with parental BMMSCs. These effects were associated with the ability of NG2/BMMSCs to differentiate into bile duct cells (BDCs). In particular, we discovered for the first time that NG2/BMMSCs exhibit unique characteristics that differ from those of parental BMMSCs in terms of producing liver sinusoidal endothelial cells (LSECs) to reconstruct injured blood vessels and sinusoidal structures in the diseased livers, which are important for initiating hepatocyte regeneration. This unique potential may also suggest that NG2/BMMSCs could be an novel off-liver progenitor of LSECs. Ex vivo studies revealed that the NG2/BMMSCs exhibited a similar trend to that of their in vivo in terms of functional differentiation responding to the DEN-diseased injured liver cues. Additionally, the obvious core role of NG2/BMMSCs in supporting the functions of BMMSCs in bile duct repair and BDC-mediated hepatocyte regeneration might also be a novel finding.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
63 more claims
Create a free account to see all 120 claims and to verify the 5 references still open.
- Probably not a substantial claim. 16
- It may state two separate claims as one. 43
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recently, Hu et al. showed that NG2+ BM-MSCs exhibited enhanced capabilities in bile duct repair and liver regeneration compared to parental BM-MSCs [398].”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [398]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“with an approximately 1.5-fold improvement in the efficacy of m-NG2/BMMSCs compared with that of m-BMMSCs for CK17 (14.17 ± 5.99/6.12 ± 3.83)”
§ New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis > Results > Advantages of donor m-NG2/BMMSCs in promoting endogenous BDCs repair and functional recovery in DEN-induced liver fibrosis/cirrhosis mouse model
Reported 1.5 · recomputed 2.315359
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“and an approximately 2.3-fold improvement for CK19 (26.71 ± 4.39/14.50 ± 3.57, Fig. 3Cc).”
§ New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis > Results > Advantages of donor m-NG2/BMMSCs in promoting endogenous BDCs repair and functional recovery in DEN-induced liver fibrosis/cirrhosis mouse model
Reported 2.3 · recomputed 1.842069
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“the number of host CK19+ cholangiocytes (red) was greater (29.18 ± 3.96; Fig. 6Da; left panels) than that of the mice that received parental h-BMMSCs (8.50 ± 4.62; Fig. 6Da; right panels; b, arrows), an approximately 4.5-fold increase (Fig. 6Dc).”
§ New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis > Results > Characterization of ex vivo-expanded NG2+ cells isolated from human marrow MSCs and the advantages of these cells in exerting therapeutic effects on DEN-induced liver disease
Reported 4.5 · recomputed 3.432941
Citations
Cites
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Tsochatzis, E. A., Bosch, J., & Burroughs, A. K. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60121-5 · Cited by 1,740
Brunt, E. M., Kleiner, D. E., Wilson, L. A., Belt, P., & Neuschwander-Tetri, B. A. (2011) · Hepatology · doi:10.1002/hep.24127 · Cited by 1,251 · cited 1×
“A semi-quantitative scoring was performed by a pathologist blinded to different study groups based on a standard Non-alcoholic fatty liver disease (NAFLD) Activity Score (NAS) or criteria [26] which commonly used in preclinical animal models and in patients [27, 28] from H&E staining.”
MethodStem cell-based therapy for human diseases
Hoang, D. M., Pham, P. T., Bach, T. Q., Ngo, A. T. L., Nguyen, Q. T., Phan, T. T. K., Nguyen, G. H., Le, P. T. T., Hoang, V. T., Forsyth, N. R., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01134-4 · Cited by 1,074 · cited 1×
“MSCs can be isolated from multiple organ tissues, such as bone marrow [2], adipose tissue [3], umbilical cord blood [4] etc., although in lower numbers, while similar functional benefits have been observed.”
BackgroundLiver sinusoidal endothelial cells: Physiology and role in liver diseases
Poisson, J., Lemoinne, S., Boulanger, C., Durand, F., Moreau, R., Valla, D., & Rautou, P.-E. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.009 · Cited by 1,047 · cited 1×
“…the mechanism is that direct LSEC differentiation from NG2/ BM MSCs to reconstruct sinusoidal structures and initiate overall regeneration [51] results in functional recovery, leading to therapeutic effects; this contribution is unique for NG2/ BM MSCs because BM MSCs cannot complete this…”
BackgroundBai, L., Lennon, D. P., Caplan, A. I., DeChant, A., Hecker, J., Kranso, J., Zaremba, A., & Miller, R. H. (2012) · Nature Neuroscience · doi:10.1038/nn.3109 · Cited by 421 · cited 1×
“…that mediate enhanced endogenous regeneration of NG2/ BM MSCs also remains unknown but may include growth factors such as hepatocyte growth factor (HGF), Interlukin-6 (IL-6), and the CCAAT/enhancer binding proteins (C/EBPs) [8, 54, 55], all of which are implicated in modulating liver tissue repair.”
Self-citationDiethylnitrosamine (DEN)-induced carcinogenic liver injury in mice
Tolba, R., Kraus, T., Liedtke, C., Schwarz, M., & Weiskirchen, R. (2015) · Laboratory Animals · doi:10.1177/0023677215570086 · Cited by 313 · cited 4×
“The characteristics of the model include three typical pathological alterations: liver fibrosis, cirrhosis and cancer [10], and these changes resulting in liver damage are quite similar to those in humans [9].”
BackgroundMethodInfluentialThe NG2 proteoglycan: Past insights and future prospects
Stallcup, W. B. (2002) · Journal of Neurocytology · doi:10.1023/a:1025731428581 · Cited by 296 · cited 1×
“One feature shared by PCs is the expression of the cell surface glycoprotein NG2 [18], which was originally defined by antibodies directed against surface proteins in a rat cell line with glial and neuronal properties [19].”
BackgroundThe Origins of Mesenchymal Stromal Cell Heterogeneity
Pevsner-Fischer, M., Levin, S., & Zipori, D. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9229-7 · Cited by 251 · cited 1×
“It may arise from distinct phenotypes in vivo, adaptation to ex vivo cultivation, or senescence upon expansion [5].”
BackgroundDiagnosis and Evaluation of Nonalcoholic Fatty Liver Disease
Obika, M., & Noguchi, H. (2012) · Experimental Diabetes Research · doi:10.1155/2012/145754 · Cited by 242 · cited 1×
“A semi-quantitative scoring was performed by a pathologist blinded to different study groups based on a standard Non-alcoholic fatty liver disease (NAFLD) Activity Score (NAS) or criteria [26] which commonly used in preclinical animal models and in patients [27, 28] from H&E staining.”
Method
Cited by
Roles of PDGF/PDGFR signaling in various organs
Jung, S., Kang, D., & Ko, E. (2024) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.24.309 · Cited by 34
Liu, W., Liu, Y., Zhang, L., Li, L., Yang, W., Li, J., & He, W. (2025) · Nature Communications · doi:10.1038/s41467-025-59885-x · Cited by 32
Pan, X., Gao, T., & Wang, B. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01520-9 · Cited by 2
“Recently, Hu et al. showed that NG2 + BM-MSCs exhibited enhanced capabilities in bile duct repair and liver regeneration compared to parental BM-MSCs [398].”
A novel off-liver sinusoidal progenitor cells in supporting transplantable bioliver engineering
Lai, J., Hu, D., Yan, M., Chen, Q., Shi, H., Yang, Q., Ding, M., Li, L., Zhang, H., & Bai, L. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214358 · Cited by 2
Self-citationFuloria, N. K., Fuloria, S., Sekar, M., Porwal, O., Ansari, M. T., Biswas, A., Narain, K., Biswas, S., Bhatia, S., & Murtey, M. D. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00509-7 · Cited by 1
Metadata
- Authors
- Hu, D., Lai, J., Chen, Q., & Bai, L.
- Affiliations
- Army Medical University (CN)
- Corresponding author
- Bai, Lianhua
- ORCID
- Bai, Lianhua
- Venue
- Stem Cell Research & Therapy
- Published
- 2024-07-06
- Volume
- 15
- Issue
- 1
- Pages
- 199-199
- ISSN
- 1757-6512 (ISSN-L)
- PMC
- PMC11227708
- OpenAlex
- W4400380331
- Semantic Scholar
- 33ac34b2a1644f9cd728cc3270cebc93360af340
- Cited by
- 6
- References
- 55
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Stem Cell Research & Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (81873586)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- bone marrow-derived mesenchymal stem cells, liver fibrosis, liver cirrhosis, cell therapy, cell isolation, stemness, SSEA-3, liver regeneration, bile duct cells, liver sinusoidal endothelial cells, hepatocyte differentiation, cellular heterogeneity
- MeSH terms
- Chondroitin Sulfate Proteoglycan 4, Animals, Antigens, Bone Marrow Cells, Cell Differentiation, Cells, Cultured, Liver Cirrhosis, Male, Mice, Inbred C57BL, Proteoglycans, Mesenchymal Stem Cell Transplantation, Cell Proliferation, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis. https://app.cochat.ai/papers/10.1186/s13287-024-03817-x
- The paper
- Hu, D., Lai, J., Chen, Q., & Bai, L. (2024). New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-024-03817-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.